Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 USD | +6.76% | +12.47% | +13.60% |
25/04 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
16/04 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.60% | 35.55M | |
+8.90% | 105B | |
-1.13% | 104B | |
+5.79% | 22.94B | |
-12.36% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.04% | 16.96B | |
+7.83% | 14.16B | |
+38.71% | 12.63B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Needham Adjusts OncoCyte's Price Target to $2.25 From $4 on 'Peer Multiple Compression,' Reiterates Buy Rating